ImmuCell Corporation

NasdaqCM:ICCC Stock Report

Market Cap: US$41.1m

ImmuCell Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:ICCC Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
17 Sep 24BuyUS$341,300SRK Capital, LLCCompany89,180US$4.19
22 May 24BuyUS$553,270SRK Capital, LLCCompany101,704US$5.44

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ICCC?
Owner TypeNumber of SharesOwnership Percentage
Hedge Funds502,2585.64%
Institutions1,155,44313%
Individual Insiders2,618,02629.4%
General Public4,635,86252%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15%.


Top Shareholders

Top 25 shareholders own 47.72% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.23%
Norman Pessin
644,019US$3.0m0%no data
5.77%
Jonathan Rothschild
514,003US$2.4m0%no data
5.64%
SRK Capital, LLC
502,258US$2.3m28.4%100.0%
5.2%
Ejnar Knudsen
463,619US$2.1m0%no data
4.51%
Sandra Pessin
401,819US$1.9m0%no data
2.96%
Cresset Asset Management, LLC
264,002US$1.2m27.4%no data
2.53%
The Vanguard Group, Inc.
225,595US$1.0m0%no data
2.42%
Michael Brigham
215,752US$994.6k0%no data
1.68%
Renaissance Technologies LLC
149,489US$689.1k19%no data
1.54%
Brian Pessin
136,882US$631.0k0%no data
1.48%
David Tomsche
131,797US$607.6k27.2%no data
1.14%
Bleichroeder LP
101,594US$468.3k0%0.12%
1.07%
Joseph Crabb
95,345US$439.5k0%no data
0.82%
Dimensional Fund Advisors LP
72,682US$335.1k10%no data
0.71%
Morgan Stanley, Investment Banking and Brokerage Investments
63,516US$292.8k-4.94%no data
0.7%
Shufro, Rose & Co., LLC
62,408US$287.7k0%0.02%
0.64%
Geode Capital Management, LLC
56,660US$261.2k1.73%no data
0.35%
Strategic Financial Services, Inc.
31,000US$142.9k0%0.01%
0.33%
Northern Trust Global Investments
29,392US$135.5k2.91%no data
0.24%
HighTower Advisors, LLC
21,354US$98.4k0%no data
0.18%
Prosperity Planning, Inc.
16,000US$73.8k0%0.02%
0.18%
UBS Asset Management AG
15,942US$73.5k496%no data
0.16%
BlackRock, Inc.
14,312US$66.0k3.98%no data
0.14%
Mesirow Financial Investment Management, Inc.
12,178US$56.1k0%no data
0.12%
Essex Financial Services, Inc.
11,000US$50.7k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 22:16
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ImmuCell Corporation is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nathan WeinsteinAegis Capital Corporation